Objectives: Amyloid-β (Aβ) deposition in the brain is the hallmark of Alzheimer's disease
(AD) pathology. Hypertension is a risk factor for AD, but the effects of hypertension on Aβ …

Abstract Background/Aims: Studies on the relation between blood pressure (BP), dementia
and Alzheimer's disease (AD) have yielded inconsistent results, showing an association with …

Background Hypertension is the strongest modifiable risk factor for subcortical ischemic
changes and is also a risk factor for Alzheimer's dementia. We used neuroimaging to …

Objective Elevated vascular risk and beta‐amyloid (Aβ) burden have been synergistically
associated with cognitive decline in preclinical Alzheimer's disease (AD), although the …

Relationship between late-life hypertension and Alzheimer's disease (AD) remains less
clear. Both cross-sectional and longitudinal methods were used to examine whether systolic …

Background Alzheimer's disease (AD) is a neurological disorder of unknown cause,
resulting in the death of brain cells. Identifying some of the modifiable risk factors for AD …

Abstract Background: Cardiovascular disease (CVD), including elevated blood pressure
(BP), is known to promote Alzheimer's disease (AD) risk. Although brain amyloid load is a …

Background: Elevated blood pressure is linked to cognitive impairment and Alzheimer's
disease (AD) biomarker abnormality. However, blood pressure levels vary over time. Less is …

Several studies report that blood pressure is increased in victims of Alzheimer's disease
(AD) decades before the onset of the disease. Years before onset of Alzheimer's disease …

Background: Alzheimer's disease (AD) pathology and hypertension (HTN) are risk factors for
development of white matter (WM) alterations and might be independently associated with …